AAA patent dispute
This article was originally published in The Gray Sheet
Shaun Samuels, MD, Baptist Cardiac & Vascular Institute, Miami, alleges that Boston Scientific's TriVascular Enovus abdominal aortic stent graft infringes his patent for "inflatable intraluminal stent and method for affixing same within the human body" and was derived from Samuels' trade secret technology. Samuels is represented by Morgan & Finnegan, LLP, New York. Boston Scientific responds: "Dr. Samuels has raised these allegations before, in a lawsuit which he filed and subsequently withdrew. We have had an opportunity to look into his claims, and we believe they are groundless. We will defend this lawsuit vigorously"...
You may also be interested in...
The company will use the proceeds to fund clinical trials, expand commercialization of its targeted radiation therapy, and file for CE marking in Europe.
Advanced Medical Solutions said it will buy Raleigh Adhesive Coatings for £22m ($29m) in cash to strengthen its overall wound care business.
While Amgen said the Phase III GALACTIC-HF results for omecamtiv mecarbil did not meet its high expectations for the heart failure candidate, Cytokinetics sees a path to treating certain patients.